Harrison-Phipps Karen M, Nichols Francis C, Schleck Cathy D, Deschamps Claude, Cassivi Stephen D, Schipper Paul H, Allen Mark S, Wigle Dennis A, Pairolero Peter C
Division of General Thoracic Surgery, Mayo Clinic, Rochester, Minn 55905, USA.
J Thorac Cardiovasc Surg. 2009 Jul;138(1):19-25. doi: 10.1016/j.jtcvs.2009.01.026.
We sought to define the long-term outcome of surgically treated solitary fibrous tumors of the pleura.
We performed a retrospective review from December 1972 through December 2002.
There were 84 patients (39 men and 45 women) with a median age of 57 years (range, 34-83 years). Forty-six patients were symptomatic. Surgical resection included pulmonary wedge excision in 62 patients, lobectomy in 4 patients, segmentectomy in 2 patients, chest wall resection in 3 patients, isolated pleural resection in 7 patients, and chest wall resection with pulmonary wedge excision, lobectomy, or pneumonectomy in 3, 2, and 1 patients, respectively. Tumors were polypoid in 57 patients, sessile in 20 patients, and intrapulmonary in 7 patients. Histopathology was benign in 73 and malignant in 11 patients. Nine (82%) patient with malignant tumors and 37 (54%) patients with benign tumors were symptomatic (P = .11). The median tumor diameters for malignant and benign tumors were 12.0 and 4.5 cm, respectively (P = .001). Operative mortality and morbidity occurred in 3 (3.6%) and 7 (8.1%) patients, respectively. Median follow-up in survivors was 146 months (range, 23-387 months). Median survival for patients with benign and malignant tumors was 284 and 55 months, respectively, and 5-year survival was 88.9% and 45.5%, respectively (P = .0005). Eight (9.5%) patients had recurrent solitary fibrous tumors of the pleura. Recurrences were malignant in 6 and benign in 2 patients. Localized chest recurrences occurred in 3 patients, all of whom had reresection, with 2 patients again having recurrence.
Resection of benign solitary fibrous tumors of the pleura carries an excellent prognosis. Larger tumors are more likely to be malignant. Both benign and malignant tumors can recur. Although prolonged survival after resection of malignant tumors is possible, recurrence is common.
我们试图明确手术治疗的胸膜孤立性纤维瘤的长期预后情况。
我们对1972年12月至2002年12月期间的病例进行了回顾性研究。
共有84例患者(39例男性和45例女性),中位年龄为57岁(范围34 - 83岁)。46例患者有症状。手术切除方式包括62例行肺楔形切除术、4例行肺叶切除术、2例行肺段切除术、3例行胸壁切除术、7例行单纯胸膜切除术,以及分别有3例、2例和1例患者行胸壁切除联合肺楔形切除术、肺叶切除术或全肺切除术。57例患者的肿瘤呈息肉样,20例呈无蒂状,7例位于肺内。组织病理学检查显示73例为良性,11例为恶性。9例(82%)恶性肿瘤患者和37例(54%)良性肿瘤患者有症状(P = 0.11)。恶性和良性肿瘤的中位肿瘤直径分别为12.0 cm和4.5 cm(P = 0.001)。手术死亡率和发病率分别发生在3例(3.6%)和7例(8.1%)患者中。存活患者的中位随访时间为146个月(范围23 - 387个月)。良性和恶性肿瘤患者的中位生存期分别为284个月和55个月,5年生存率分别为88.9%和45.5%(P = 0.0005)。8例(9.5%)患者出现胸膜孤立性纤维瘤复发。6例复发为恶性,2例为良性。3例患者出现局部胸部复发,均再次接受了切除手术,其中2例再次复发。
胸膜良性孤立性纤维瘤切除术后预后良好。较大的肿瘤更可能为恶性。良性和恶性肿瘤均可复发。虽然恶性肿瘤切除术后有可能延长生存期,但复发很常见。